{"id":"antenatal-steroids-administration","safety":{"commonSideEffects":[{"rate":null,"effect":"Maternal hyperglycemia"},{"rate":null,"effect":"Increased infection risk (maternal)"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL2029079","moleculeType":"Small molecule","molecularWeight":"738.91"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Corticosteroids administered to pregnant women at risk of preterm delivery cross the placenta and stimulate fetal lung development, particularly increasing production of pulmonary surfactant—a critical substance that reduces surface tension in alveoli and enables proper gas exchange. This intervention significantly reduces neonatal mortality, respiratory distress syndrome, and intraventricular hemorrhage in infants born prematurely.","oneSentence":"Antenatal steroids (typically corticosteroids like betamethasone or dexamethasone) accelerate fetal lung maturity by promoting surfactant production, reducing respiratory distress syndrome risk in preterm infants.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:47.314Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of respiratory distress syndrome in preterm infants (gestational age 24–34 weeks at risk of preterm delivery)"},{"name":"Reduction of neonatal mortality and morbidity in threatened preterm labor"}]},"trialDetails":[{"nctId":"NCT07358845","phase":"","title":"Hematological Profiles of Preterm Infants and the Impact of Antenatal Steroids","status":"COMPLETED","sponsor":"Princess Anna Mazowiecka Hospital, Warsaw, Poland","startDate":"2011-01-02","conditions":"Haematology","enrollment":1048},{"nctId":"NCT07107477","phase":"PHASE3","title":"TAILORED Therapeutic Regime in Patients With Preterm Premature Rupture Of Membranes to Prolong Pregnancy, Improve Maternal and Neonatal Outcomes, and Reduce Antibiotic Burden","status":"RECRUITING","sponsor":"The Central and Eastern European Gynecologic Oncology Group","startDate":"2025-05-01","conditions":"Preterm Premature Rupture of Membranes (PPROM)","enrollment":138},{"nctId":"NCT06188195","phase":"NA","title":"Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2024-02-01","conditions":"Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome, Acute","enrollment":500},{"nctId":"NCT04831086","phase":"PHASE3","title":"To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis","status":"COMPLETED","sponsor":"Fundacion Clinic per a la Recerca Biomédica","startDate":"2021-05-05","conditions":"Preterm Birth, Preterm Labor, Intra-amniotic Infection","enrollment":247},{"nctId":"NCT00920621","phase":"PHASE3","title":"Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-09","conditions":"Asthma","enrollment":876},{"nctId":"NCT06164080","phase":"NA","title":"The Effect Of Antenatal Corticosteroids On Early And Late Perinatal Outcomes","status":"COMPLETED","sponsor":"Sanliurfa Mehmet Akif Inan Education and Research Hospital","startDate":"2021-06-01","conditions":"Preterm Pregnancy, Antenatal Corticosteroid, Perinatal Problems","enrollment":459},{"nctId":"NCT02814929","phase":"","title":"Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey","status":"COMPLETED","sponsor":"Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital","startDate":"2016-04-01","conditions":"Retinopathy of Prematurity","enrollment":6115},{"nctId":"NCT05640596","phase":"","title":"Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2014-01-01","conditions":"Growth Retardation","enrollment":363},{"nctId":"NCT03076775","phase":"NA","title":"Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-06-08","conditions":"Pregnancy Preterm, Neonatal Hypoglycemia, Hyperglycemia Drug Induced","enrollment":86},{"nctId":"NCT03562182","phase":"","title":"Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA","status":"UNKNOWN","sponsor":"Wayne State University","startDate":"2018-06-18","conditions":"Fetal Lung Maturity, Respiratory Distress Syndrome in Premature Infant","enrollment":80},{"nctId":"NCT03668860","phase":"PHASE1","title":"India Dexamethasone and Betamethasone","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-09-20","conditions":"Preterm Birth, Antenatal Corticosteroids","enrollment":48},{"nctId":"NCT03202836","phase":"NA","title":"Vaginal Progesterone Supplementation in the Management of Preterm Labor","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2017-06-29","conditions":"Preterm Labor","enrollment":90},{"nctId":"NCT00194987","phase":"PHASE2, PHASE3","title":"A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2001-04","conditions":"Alloimmune Thrombocytopenia, Fetal Alloimmune Thrombocytopenia","enrollment":102},{"nctId":"NCT03473210","phase":"NA","title":"The Value of Amniopatch in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-10-01","conditions":"Preterm Premature Rupture of Membrane","enrollment":100},{"nctId":"NCT02978976","phase":"PHASE4","title":"Effect of Antenatal Steroid on Pulmonary Artery Blood Flow","status":"UNKNOWN","sponsor":"Kasr El Aini Hospital","startDate":"2017-01","conditions":"Neonatal Respiratory Distress","enrollment":126},{"nctId":"NCT02272387","phase":"NA","title":"Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?","status":"TERMINATED","sponsor":"St. Luke's-Roosevelt Hospital Center","startDate":"2014-10","conditions":"Depression, Postpartum Depression","enrollment":151},{"nctId":"NCT00670956","phase":"PHASE1, PHASE2","title":"Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2008-04","conditions":"Congenital Cystic Adenomatoid Malformation","enrollment":1},{"nctId":"NCT00000563","phase":"PHASE3","title":"Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1976-06","conditions":"Lung Diseases, Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT00675246","phase":"NA","title":"Antenatal Corticoid Therapy for Late Preterm Babies","status":"COMPLETED","sponsor":"Instituto Materno Infantil Prof. Fernando Figueira","startDate":"2008-05","conditions":"Hyaline Membrane Disease, Transient Tachypnea","enrollment":320}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Antenatal steroids administration","genericName":"Antenatal steroids administration","companyName":"The Central and Eastern European Gynecologic Oncology Group","companyId":"the-central-and-eastern-european-gynecologic-oncology-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antenatal steroids (typically corticosteroids like betamethasone or dexamethasone) accelerate fetal lung maturity by promoting surfactant production, reducing respiratory distress syndrome risk in preterm infants. Used for Prevention of respiratory distress syndrome in preterm infants (gestational age 24–34 weeks at risk of preterm delivery), Reduction of neonatal mortality and morbidity in threatened preterm labor.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}